Development and characterization of a nanoemulsion containing propranolol for topical delivery

Abstract

We concluded that the formulation is safe for skin administration; however, cutaneous irritation studies should be performed to confirm the safety of the formulation before clinical studies in patients with infantile hemangiomas.